Search

Your search keyword '"Polus F"' showing total 119 results

Search Constraints

Start Over You searched for: "Polus F" Remove constraint "Polus F"
119 results on '"Polus F"'

Search Results

1. Spinal anesthesia in patients with aortic stenosis: a research report.

2. Non-invasive candidate protein signature predicts hepatic venous pressure gradient reduction in cirrhotic patients after sustained virologic response.

4. Angiopoietin-like 3-derivative LNA043 for cartilage regeneration in osteoarthritis: a randomized phase 1 trial.

5. Evaluation of a comprehensive pre-procedural screening protocol for COVID-19 in times of a high SARS CoV-2 prevalence: a prospective cross-sectional study.

6. A new viewpoint on endoscopic CABG: technique description and clinical experience.

7. β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis.

8. Secukinumab distributes into dermal interstitial fluid of psoriasis patients as demonstrated by open flow microperfusion.

9. Pharmacokinetic and pharmacodynamic interaction of siponimod (BAF312) and propranolol in healthy subjects.

10. The Contribution of the Skin Microbiome to Psoriasis Pathogenesis and Its Implications for Therapeutic Strategies.

11. Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.

13. A translocated effector required for Bartonella dissemination from derma to blood safeguards migratory host cells from damage by co-translocated effectors.

14. Evaluation of Kynu, Defb2, Camp, and Penk Expression Levels as Psoriasis Marker in the Imiquimod‐Induced Psoriasis Model.

16. Proteomics in Psoriasis: Recent Advances.

17. Multimodality Cardiovascular Imaging for Totally Video-Guided Thorascopic Cardiac Surgery.

18. Successful Treatment with Bimekizumab of a Psoriatic Patient Undergoing Hemodialysis: A Case Report and Review of the Literature.

19. The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers.

20. Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis.

21. Advancements in understanding the molecular and immune mechanisms of Bartonella pathogenicity.

23. Correlations between antimicrobial peptides and spectrophotometric skin color parameters in patients with basal cell carcinoma.

24. The Emerging Role of Innate Lymphoid Cells (ILCs) and Alarmins in Celiac Disease: An Update on Pathophysiological Insights, Potential Use as Disease Biomarkers, and Therapeutic Implications.

25. Patient-Centred Outcomes after Totally Endoscopic Cardiac Surgery: One-Year Follow-Up.

26. Targeted Therapies in Psoriatic Arthritis—An Update.

27. Preoperative SARS-CoV-2 Infection Screening before Thoracic Surgery during COVID-19 Pandemic: A Multicenter Retrospective Study.

28. Gelsolin as a Potential Clinical Biomarker in Psoriasis Vulgaris.

30. In vivo monitoring of brain pharmacokinetics and pharmacodynamics with cerebral open flow microperfusion.

32. The Clinical Significance of Simultaneous IL-17A and IL-17F Blockade in Psoriasis Non-Responding to Anti-IL17A Therapy.

33. Akkermansia muciniphila and Faecalibacterium prausnitzii in Immune-Related Diseases.

34. totally endoscopic approach for aortic valve surgery.

35. Dermal open flow microperfusion for PK-based clinical bioequivalence studies of topical drug products.

36. Transcriptome Meta-Analysis Confirms the Hidradenitis Suppurativa Pathogenic Triad: Upregulated Inflammation, Altered Epithelial Organization, and Dysregulated Metabolic Signaling.

37. Profiling Serum Cytokines and Anticytokine Antibodies in Psoriasis Patients.

38. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Moderate-to-Severe Psoriasis.

39. Comparative Study of Dermal Pharmacokinetics Between Topical Drugs Using Open Flow Microperfusion in a Pig Model.

40. Advanced Online Monitoring of In Vitro Human 3D Full-Thickness Skin Equivalents.

42. Clinical results after hybrid coronary revascularization with totally endoscopic coronary surgery.

43. 90-Day Patient-Centered Outcomes after Totally Endoscopic Cardiac Surgery: A Prospective Cohort Study.

44. Minimal Physiologically-Based Pharmacokinetic (mPBPK) Metamodeling of Target Engagement in Skin Informs Anti-IL17A Drug Development in Psoriasis.

45. Proteomic Studies of Psoriasis.

46. Comparison of monoclonal antibody disposition predictions using different physiologically based pharmacokinetic modelling platforms.

48. Low-Density Granulocytes in Immune-Mediated Inflammatory Diseases.

49. Abuse and dependence potential of sphingosine-1-phosphate (S1P) receptor modulators used in the treatment of multiple sclerosis: a review of literature and public data.

50. The Impact of Bartonella VirB/VirD4 Type IV Secretion System Effectors on Eukaryotic Host Cells.

Catalog

Books, media, physical & digital resources